3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
5
NIH
1
NETWORK
1
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Breast Neoplasms
30
Prostatic Neoplasms
19
Carcinoma, Non-Small-Cell Lung
18
Lung Neoplasms
14
Head and Neck Neoplasms
12
Squamous Cell Carcinoma of Head and Neck
11
Ovarian Neoplasms
7
Carcinoma, Ovarian Epithelial
5
Adenocarcinoma of Lung
5
Inflammatory Breast Neoplasms
4
Fallopian Tube Neoplasms
4
Esophageal Neoplasms
4
Unspecified Adult Solid Tumor, Protocol Specific
3
Salivary Gland Neoplasms
3
Pancreatic Neoplasms
3
Neoplasm Metastasis
3
Breast Neoplasms, Male
3
Adenocarcinoma
3
Urinary Bladder Neoplasms
2
Stomach Neoplasms
2
Recurrent Uterine Corpus Sarcoma
2
Recurrent Squamous Cell Lung Carcinoma
2
Carcinoma
2
Anatomic Stage I Breast Cancer AJCC v8
2
Adenocarcinoma Of Esophagus
2
Uterine Cervical Neoplasms
1
Urethral Neoplasms
1
Thyroid Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Thyroid Cancer, Papillary
1
Interventions
Ifosfamide
5
Doxorubicin
4
Specimen Handling
3
Methotrexate
3
Etoposide
3
Cisplatin
3
Sorafenib
2
Granulocyte Colony-Stimulating Factor
2
Filgrastim
2
sodium thiosulfate
1
sargramostim
1
pepinemab
1
peginterferon alfa-2b
1
mifamurtide
1
merphos
1
lorukafusp alfa
1
irinotecan sucrosofate
1
imetelstat
1
etoposide phosphate
1
Zoledronic Acid
1
X-Rays
1
Thrombopoietin
1
Thoracotomy
1
Thoracostomy
1
Thoracoscopy
1
Surgical Procedures, Operative
1
Reverse Transcriptase Polymerase Chain Reaction
1
Restraint, Physical
1
Razoxane
1
Radiotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Osteosarcoma
×
Docetaxel
×
Clear all
NCT02718482
2019-05-13
OsteoREC2015
Italian Sarcoma Group
Phase 2
Terminated
7 enrolled